Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 25 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing 10 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 5 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 1 million cells
Cryopreserved ampule of Human Cord Blood CD34+ containing ≥500,000 cells
For efficient transfection of primary human CD34+ cells in the Nucleofector® I/II/2b Device
-
Validation of Th17 Cell Differentiation from Peripheral BloodLonza White Paper
-
Blood and Immune CellsFueling your next discovery with unmatched cell and donor variety
-
Lonza - Closer Than You Think - Corporate Brochure
-
Feel The Pulse of Endotoxin Detection and Impact its Future4th Global Endotoxin Testing Summit – Agenda
-
TechSheet - Lung Blood Microvascular Endothelial Cell SystemsTechnical information sheet for Clonetics™ Lung Blood Microvascular Endothelial Cells
-
TechSheet - Dermal Blood Microvascular Endothelial Cell SystemsTechnical information sheet for Clonetics™ Dermal Blood Microvascular Endothelial Cells
-
siRNA Transfection Protocol for Blood LymphocytesInstructions of use for transfection of human peripheral blood lympohocytes with siRNA using the Nucleofector™ Technology
-
Normal Peripheral Blood CD4+ T LymphocytesLonza Application Notes
-
Cryopreservation of Peripheral Blood Mononuclear CellsDoes Not Alter Immune Cell Phenotype
-
Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic ResearchLonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf